graphic illustration of a doctor pointing at a holographic image on the brain

PRESTIGE-AF at ESOC19 in pictures

The European Stroke Organisation Conference (ESOC) is a premier European forum for stroke research and rapidly becoming the global platform for the release of major trial data.

The PRESTIGE-AF team went to ESOC 2019 in Milan of which several members of the team presented and showcased. Alongside the main conference, the PRESTIGE-AF local investigators were invited to a meeting specific to PRESTIGE-AF activities and project status.

Here is the conference in photos taken by the PRESTIGE-AF team. Enjoy!

outside a convention centre in Milan. ESCO2019 flag waving
entrance to the convention centre in Milan with sign 'Welcome to ESOC2019'
This and above: The team arriving for the first day of ESOC
Prof Stephanie Debette (Universite de Bordeaux, PRESTIGE-AF consortium member and leader of the genetics component) sitting on a panel with Rustam Al-Shahi Salman (University of Edinburgh, Edinburgh, Scotland) and two other people
Prof Stephanie Debette (Universite de Bordeaux, PRESTIGE-AF consortium member and leader of the genetics component) on the panel as a mentor giving feedback on young researchers’ protocols. Also in the photo (far left) is Rustam Al-Shahi Salman (University of Edinburgh, Edinburgh, Scotland) who is a leader in haemorrhage research and part of the RESTART trial.
Prof Stephanie Debette presenting at the conference with “My Journey, Highs and Lows in Stroke Research”.
Prof Stephanie Debette standing at a podium with microphone
This and above: Prof Stephanie Debette presenting at the conference with “My Journey, Highs and Lows in Stroke Research”.
Dr Eleni Korompoki standing at a podium presenting at ESOC2019
Dr Eleni Korompoki standing at a podium presenting at ESOC2019
This and above: Dr Eleni Korompoki (member of the Imperial College London team for PRESTIGE-AF team) presenting in the transient ischemic attack (TIA) session.
outside conference centre looking at ESOC sign
ESOC day 2!
Prof Roland Veltkamp presenting at a podium with a big screen of ICH data
Prof Roland Veltkamp (Imperial College London, UK) in the controversies in stroke debate. Prof Veltkamp was arguing in the affirmative for starting anticoagulants after intracerebral hemorrhage (ICH).
Prof Karin Klijn presenting at a podium with a big screen of ICH data
Prof Roland Veltkamp (Imperial College London, UK) above] in the controversies in stroke debate with Prof Karin Klijn (Radboud University) [here] – Prof Veltkamp was arguing in the affirmative for starting anticoagulants after intracerebral hemorrhage (ICH) with Prof Klijn as the opposing.
award winners on stage at ESOC2019
ESOC award winners including PRESTIGE-AF’s very own Prof Stephanie Debette!
Dr Yanzhong Wang on a big screen with a slide title 'Burden of Stroke in Europe: 30-year projections of incidence, prevalence, deaths, and disability-adjusted life years (DALYs)'
PRESTIGE/AF collaborator Dr Wang discussing the burden of stroke over the next 30 years
A female standing at a podium presenting with a big screen of powerpoint slides
The PRESTIGE-AF team were eagerly anticipating the presentation of the results of the PRACTISE Trial. Amongst a full house in the “Large Clinical Trials” session the PRACTISE trial demonstrated that when patients were given multimodal imaging, 1 in 5 patients were given IV thrombolysis without any reduction in patient outcomes. Extra imaging may reduce unnecessary thrombolysis in patients.
crowd shot of people looking at a big screen
The PRESTIGE-AF team were eagerly anticipating the presentation of the results of the PRACTISE Trial. Amongst a full house in the “Large Clinical Trials” session the PRACTISE trial demonstrated that when patients were given multimodal imaging, 1 in 5 patients were given IV thrombolysis without any reduction in patient outcomes. Extra imaging may reduce unnecessary thrombolysis in patients.
A man speaking at a podium with a big screen to a crowd of people
Results of sub analysis of WAKE-UP trial: thrombolysis is effective in large vessel occlusion stroke patients with unknown symptom onset and gives twice the likelihood of a favourable outcome.
exit of convention centre in Milan with sign 'Save the Date ESO-WSO Conference, Vienna 12-15 May 2020'
Conference ends at 15.45. It’s a wrap! We will see PRESTIGE-AF next year in Vienna!
outside conference centre looking at ESOC sign
Posted: 25th June 2019
See All Articles